Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Zacks Investment Research on MSN5d
DXCM Stock Gains Following New Data on Upcoming G7 CGM SensorDexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback